In an aging population vascular disorders well exemplified by the chronic limb ischemia, chronic heart failure, cerebral ischemia and age-related macular degeneration represent a serious medical and socio-economical problem. While there is always a not easily identifiable first pathogenic noxa, all of these diseases are characterized by ischemia, chronic inflammation and tissue degeneration. Orthodox medicine has provided several optimal drugs targeting various pathological situations but, even with their concomitant applications, it is not possible to reduce the chronic oxidative stress. Here it is proposed to associate the approach of ozonated autohemotherapy as a modifier of the biological response capable to block the pathological progress. © Bentham Science Publishers Ltd.

Bocci, V., Travagli, V., Zanardi, I. (2009). May oxygen-ozone therapy improves cardiovascular disorders?. CARDIOVASCULAR & HAEMATOLOGICAL DISORDERS - DRUG TARGETS, 9(2), 78-85 [10.2174/187152909788488681].

May oxygen-ozone therapy improves cardiovascular disorders?

Bocci V.;Travagli V.;Zanardi I.
2009-01-01

Abstract

In an aging population vascular disorders well exemplified by the chronic limb ischemia, chronic heart failure, cerebral ischemia and age-related macular degeneration represent a serious medical and socio-economical problem. While there is always a not easily identifiable first pathogenic noxa, all of these diseases are characterized by ischemia, chronic inflammation and tissue degeneration. Orthodox medicine has provided several optimal drugs targeting various pathological situations but, even with their concomitant applications, it is not possible to reduce the chronic oxidative stress. Here it is proposed to associate the approach of ozonated autohemotherapy as a modifier of the biological response capable to block the pathological progress. © Bentham Science Publishers Ltd.
2009
Bocci, V., Travagli, V., Zanardi, I. (2009). May oxygen-ozone therapy improves cardiovascular disorders?. CARDIOVASCULAR & HAEMATOLOGICAL DISORDERS - DRUG TARGETS, 9(2), 78-85 [10.2174/187152909788488681].
File in questo prodotto:
File Dimensione Formato  
Cardiovascular & Haematological Disorders - Drug Targets 2009 78-85.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 169.82 kB
Formato Adobe PDF
169.82 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/8294
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo